Burning Rock Biotech Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Burning Rock Biotech Limited (BNR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of CNY 49.58 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-04-28
CNY
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | 49.58M CNY 20-F · filed 2026-04-28 |
| 2024-12-31 | 987.92M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 39.41M CNY 20-F · filed 2026-04-28 |
| 2022-12-31 | 23.82M CNY 20-F · filed 2025-04-29 |
| 2021-12-31 | 21.21M CNY 20-F · filed 2024-04-29 |
| 2020-12-31 | 3.58M CNY 20-F · filed 2023-04-20 |
| 2019-12-31 | 9.48M CNY 20-F · filed 2022-04-29 |
| 2018-12-31 | 491.00K CNY 20-F · filed 2021-03-23 |
USD
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | $7.09M 20-F · filed 2026-04-28 |
| 2024-12-31 | $135.34M 20-F · filed 2025-04-29 |
| 2023-12-31 | $5.55M 20-F · filed 2024-04-29 |
| 2022-12-31 | $3.45M 20-F · filed 2023-04-20 |
| 2021-12-31 | $3.33M 20-F · filed 2022-04-29 |
| 2020-12-31 | $549.00K 20-F · filed 2021-03-23 |